- Politics
- Diversity, equity and inclusion
- Financial Decision Making
- Telehealth
- Patient Experience
- Leadership
- Point of Care Tools
- Product Solutions
- Management
- Technology
- Healthcare Transformation
- Data + Technology
- Safer Hospitals
- Business
- Providers in Practice
- Mergers and Acquisitions
- AI & Data Analytics
- Cybersecurity
- Interoperability & EHRs
- Medical Devices
- Pop Health Tech
- Precision Medicine
- Virtual Care
- Health equity
ReadyDock's David Engelhardt on Technology to Kill MRSA, C. Diff
In Part 2 of his interview with HCA News, David Engelhardt, the founder of ReadyDock Inc., discussed the company's chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.
David Engelhardt, the founder of ReadyDock Inc., met up with HCA News for an interview at the HIMSS17 conference in Orlando, Florida. ReadyDock is chemical-free mobile and tablet disinfection device designed to mitigate the burden of hospital-acquired infections. Here, Engelhardt details how ReadyDock’s technology works and infection-causing bacteria it can kill.
Cybersecurity panel: How hospitals can protect their patients and their systems
November 18th 2024Chief Healthcare Executive® presents the final installment in our series, with experts from HIMSS, the American Hospital Association, and Providence. In this episode, our panel offers advice on how health systems can improve.
